Trials / Unknown
UnknownNCT01629810
Use of Whole-Body Periodic Acceleration Therapy To Aches and Pains
An Unblinded Crossover Study of The Use of Whole-Body Periodic Acceleration Therapy To Treat Pain, Stiffness, Abnormal Gait and Balance
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Center for Translational Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the effectiveness of whole body periodic acceleration for helping with symptoms of aches and pains suffered by many patients.
Detailed description
This is an unblinded cross-over study of whole-body periodic acceleration (WBPA) to ascertain if this treatment modality provides symptomatic relief of pain, stiffness, and abnormal gait and balance in a variety of conditions. The study will compare a specific mechanism of motion, whole-body periodic acceleration (WBPA), that has been shown to increase the release of beneficial mediators from the vascular endothelium into the circulation, to a control condition of slow passive motion that promotes relaxation but does not increase release of beneficial mediators into the circulation. The study tests the efficacy and safety of a commercially available device that consists of a motion platform, called Exer-Rest©, that is capable of producing both types of motion to be tested. In this investigation, 15 subjects will be randomly assigned to either procedure for 10 treatments for 2 weeks followed by a one-week "wash-out" period. Then the opposite treatment will be employed for two weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Whole body periodic acceleration (Exer-Rest) | Lying on the vibrating bed for 45 minutes per session for 10 sessions over 2 weeks. |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2013-08-01
- First posted
- 2012-06-28
- Last updated
- 2012-06-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01629810. Inclusion in this directory is not an endorsement.